These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23565921)

  • 1. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
    Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
    ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.
    Grimm MO; Zinser EG; Grösgen S; Hundsdörfer B; Rothhaar TL; Burg VK; Kaestner L; Bayer TA; Lipp P; Müller U; Grimm HS; Hartmann T
    PLoS One; 2012; 7(3):e34095. PubMed ID: 22470521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.
    Ariga T; Yanagisawa M; Wakade C; Ando S; Buccafusco JJ; McDonald MP; Yu RK
    ASN Neuro; 2010 Oct; 2(4):e00044. PubMed ID: 20930939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Gangliosides in Alzheimer's Disease: Increased Expression of Cholinergic Neuron-Specific Gangliosides.
    Fukami Y; Ariga T; Yamada M; Yuki N
    Curr Alzheimer Res; 2017; 14(6):586-591. PubMed ID: 28124591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.
    Ariga T
    Mol Neurobiol; 2017 Jan; 54(1):623-638. PubMed ID: 26748510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice.
    Koon NA; Itokazu Y; Yu RK
    ASN Neuro; 2015; 7(6):. PubMed ID: 26699276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GD3 is up-regulated in microglia and regulates phagocytosis following global cerebral ischemia.
    Wang J; Zhang Q; Lu Y; Dong Y; Dhandapani KM; Brann DW; Yu RK
    J Neurochem; 2021 Aug; 158(3):737-752. PubMed ID: 34133773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PS dependent APP cleavage regulates glucosylceramide synthase and is affected in Alzheimer's disease.
    Grimm MO; Hundsdörfer B; Grösgen S; Mett J; Zimmer VC; Stahlmann CP; Haupenthal VJ; Rothhaar TL; Lehmann J; Pätzold A; Zinser EG; Tanila H; Shen J; Müller U; Grimm HS; Hartmann T
    Cell Physiol Biochem; 2014; 34(1):92-110. PubMed ID: 24977484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
    Dixit S; Fessel JP; Harrison FE
    Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    LeVault KR; Tischkau SA; Brewer GJ
    J Alzheimers Dis; 2016; 49(2):301-16. PubMed ID: 26484899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.
    Dhanushkodi A; McDonald MP
    PLoS One; 2011; 6(12):e29285. PubMed ID: 22195039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.